Prothena Plc Stock Market Value
| PRTA Stock | USD 16.01 4.06 33.97% |
| Symbol | Prothena |
Prothena plc Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Prothena Plc. If investors know Prothena will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Prothena Plc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.46) | Revenue Per Share 2.482 | Quarterly Revenue Growth (0.99) | Return On Assets (0.16) | Return On Equity (0.23) |
The market value of Prothena plc is measured differently than its book value, which is the value of Prothena that is recorded on the company's balance sheet. Investors also form their own opinion of Prothena Plc's value that differs from its market value or its book value, called intrinsic value, which is Prothena Plc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Prothena Plc's market value can be influenced by many factors that don't directly affect Prothena Plc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Prothena Plc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Prothena Plc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Prothena Plc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Prothena Plc 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Prothena Plc's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Prothena Plc.
| 11/20/2024 |
| 12/20/2024 |
If you would invest 0.00 in Prothena Plc on November 20, 2024 and sell it all today you would earn a total of 0.00 from holding Prothena plc or generate 0.0% return on investment in Prothena Plc over 30 days. Prothena Plc is related to or competes with Scpharmaceuticals, Milestone Pharmaceuticals, Oncolytics Biotech, Seres Therapeutics, 89bio, Madrigal Pharmaceuticals, and Pliant Therapeutics. Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for lif... More
Prothena Plc Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Prothena Plc's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Prothena plc upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 29.85 | |||
| Value At Risk | (8.13) | |||
| Potential Upside | 8.71 |
Prothena Plc Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Prothena Plc's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Prothena Plc's standard deviation. In reality, there are many statistical measures that can use Prothena Plc historical prices to predict the future Prothena Plc's volatility.| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.33) | |||
| Total Risk Alpha | (0.45) | |||
| Treynor Ratio | (0.08) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Prothena Plc's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Prothena plc Backtested Returns
Prothena plc maintains Sharpe Ratio (i.e., Efficiency) of -0.043, which implies the firm had a -0.043% return per unit of risk over the last 3 months. Prothena plc exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Prothena Plc's Coefficient Of Variation of (2,744), risk adjusted performance of (0.02), and Variance of 43.74 to confirm the risk estimate we provide. The company holds a Beta of 3.22, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Prothena Plc will likely underperform. At this point, Prothena plc has a negative expected return of -0.29%. Please make sure to check Prothena Plc's skewness, as well as the relationship between the rate of daily change and period momentum indicator , to decide if Prothena plc performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.37 |
Poor reverse predictability
Prothena plc has poor reverse predictability. Overlapping area represents the amount of predictability between Prothena Plc time series from 20th of November 2024 to 5th of December 2024 and 5th of December 2024 to 20th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Prothena plc price movement. The serial correlation of -0.37 indicates that just about 37.0% of current Prothena Plc price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.37 | |
| Spearman Rank Test | -0.09 | |
| Residual Average | 0.0 | |
| Price Variance | 1.08 |
Prothena plc lagged returns against current returns
Autocorrelation, which is Prothena Plc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Prothena Plc's stock expected returns. We can calculate the autocorrelation of Prothena Plc returns to help us make a trade decision. For example, suppose you find that Prothena Plc has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Prothena Plc regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Prothena Plc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Prothena Plc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Prothena Plc stock over time.
Current vs Lagged Prices |
| Timeline |
Prothena Plc Lagged Returns
When evaluating Prothena Plc's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Prothena Plc stock have on its future price. Prothena Plc autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Prothena Plc autocorrelation shows the relationship between Prothena Plc stock current value and its past values and can show if there is a momentum factor associated with investing in Prothena plc.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Prothena plc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Prothena Plc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Prothena Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Prothena Plc Stock:Check out Prothena Plc Correlation, Prothena Plc Volatility and Prothena Plc Alpha and Beta module to complement your research on Prothena Plc. For information on how to trade Prothena Stock refer to our How to Trade Prothena Stock guide.You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Prothena Plc technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.